TCM
MDCO

Teza Capital Management’s Medicines Co MDCO Stock Holding History

Teza Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-10,388
Closed -$342K – 615
2018
Q1 		$342K Buy
+10,388
New +$325K 0.08% 346

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Teza Capital Management's MDCO Position: Q2 2018 in Review

Teza Capital Management sold out of Medicines Co (MDCO) in Q2 2018, closing a stake of 10,388 shares — an estimated $342K sold.

Teza Capital Management first reported a position in MDCO in Q1 2018 and held it in 1 quarter. The position peaked at $342K in Q1 2018. 188 funds tracked by Wall St. Rank hold MDCO as of Q2 2018.

  • Teza Capital Management reported no remaining Medicines Co position as of Q2 2018 after selling out during the quarter.
  • Teza Capital Management sold 10,388 Medicines Co shares in Q2 2018, an estimated $342K.
  • Teza Capital Management first reported a position in Medicines Co in Q1 2018 and held it in 1 quarter.
  • Teza Capital Management's Medicines Co position peaked at $342K in Q1 2018.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q2 2018.

Based on Teza Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.